TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 132 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $2,423,000 | +20.1% | 21,500 | +19.4% | 0.03% | +16.0% |
| Q2 2017 | $2,017,000 | -54.6% | 18,000 | -52.8% | 0.02% | -56.1% |
| Q1 2017 | $4,443,000 | -65.3% | 38,100 | -68.7% | 0.06% | -68.2% |
| Q4 2016 | $12,822,000 | +31.5% | 121,800 | +38.1% | 0.18% | +27.0% |
| Q3 2016 | $9,747,000 | +4.3% | 88,200 | +37.4% | 0.14% | +2.2% |
| Q2 2016 | $9,348,000 | +205.6% | 64,200 | +224.2% | 0.14% | +200.0% |
| Q4 2015 | $3,059,000 | – | 19,800 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 85,205 | $9,416,000 | 7.01% |
| FORT, L.P. | 149,014 | $16,468,000 | 5.67% |
| Strategic Global Advisors, LLC | 80,231 | $11,336,000 | 4.23% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 701,900 | $77,567,000 | 3.19% |
| Ativo Capital Management LLC | 78,727 | $8,700,000 | 2.01% |
| Analyst IMS Investment Management Services Ltd. | 31,438 | $3,474,000 | 1.47% |
| Parametrica Management Ltd | 4,327 | $478,000 | 1.32% |
| Freestone Capital Holdings, LLC | 89,005 | $9,836,000 | 0.90% |
| RPG Investment Advisory, LLC | 19,580 | $2,163,000 | 0.68% |
| MERITAGE PORTFOLIO MANAGEMENT | 38,465 | $4,251,000 | 0.47% |